MedTrace Logo

Optimal Fluid Resuscitation for Trauma Patients

NCT00527098 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2013-02-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if the overall fluid requirements for the first 24 hours after admission will be reduced with Hextend versus a standard of care crystalloid resuscitation fluid.

Conditions

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Kenneth G Proctor, PhD · University of Miami

  • Carl I Schulman, MD, MSPH · University of Miami

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00527098 on ClinicalTrials.gov